CN Patent

CN118834160B — Ubrelvy关键手性内酰胺中间体及其衍生物的不对称合成方法

Assigned to Institute of Materia Medica of CAMS and PUMC · Expires 2025-12-19 · 0y expired

What this patent protects

本发明属于化学合成领域，目的在于提供了一种Ubrelvy关键手性内酰胺中间体及其衍生物的不对称合成方法，其结构通式如化合物10所示，R1为芳基、杂环芳基，R2为C1‑C4的烷基、芳香基、杂环芳基，R1、R2包括R\S两种构型且R1与R2在平面同一侧，合成特征包括如下步骤：

USPTO Abstract

本发明属于化学合成领域，目的在于提供了一种Ubrelvy关键手性内酰胺中间体及其衍生物的不对称合成方法，其结构通式如化合物10所示，R1为芳基、杂环芳基，R2为C1‑C4的烷基、芳香基、杂环芳基，R1、R2包括R\S两种构型且R1与R2在平面同一侧，合成特征包括如下步骤：

Drugs covered by this patent

Patent Metadata

Patent number
CN118834160B
Jurisdiction
CN
Classification
—
Expires
2025-12-19
Drug substance claim
No
Drug product claim
No
Assignee
Institute of Materia Medica of CAMS and PUMC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.